Search

everythinglearnresearchcommunity

for

Search:↓

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Androgens regulate Sertoli cells and affect fertility through specific receptors and coregulators.

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

Gonadal hormones may influence sex differences in play fighting in animals, but their effect on human spatial behavior is unclear and needs more research.

Dutasteride did not change rat spermatogenesis or oxidative stress but needs more research.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Finasteride may cause lasting sexual issues by altering specific genes in human cells.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

Finasteride causes reproductive malformations in male rats.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Male pattern baldness does not cause an increased risk of prostate cancer.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Androgens may block hair growth signals, targeting this could treat hair loss.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Minoxidil might partially activate estrogen receptors, affecting hair growth.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Changing Allopregnanolone levels in newborns affects adult behavior and anxiety.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Androgens increase EPO production, finasteride doesn't significantly impact it.

Finasteride reduces prostate size and DHT in male mastomys but not in females.

Androgens might not be the only major factor in hair loss; other elements could also be important.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Genetic response to androgens is key in female pattern baldness, not SHBG levels.

Testosterone affects skin by increasing oil production and influences hair growth.

Antiandrogenic treatments can effectively manage certain skin conditions by using female hormones.

Testosterone makes XX skin more like male skin by changing its structure and cell makeup.